AUROBINDO PHARMA
Supplier Forensic Analysis · Scanned: 2026/07/25
Open this supplier in the workbench →These findings identify statistical unusualness and named data patterns for review. They do not establish wrongdoing and require source verification.
CIPC screening
ClearCompliance
N/A/100
Awards
3
Total Value
R 2,5B
Recent Awards
3 awards · Total: R 2 522 162 159,15
HP13-2025ARV/01: Supply and Delivery of Anti-Retroviral Medicines to the Department of Health for the period ending 30 November 2028
Health and Welfare Sector Education and Training Authority
Ref: HP13-2025ARV/01R 9 821 938,32
19 Jun 2026
HP13-2025ARV: Supply and Delivery of Anti-Retroviral Medicines to the Department of Health for the period 1 July 2025 to 30 June 2028
Health
Ref: HP13-2025ARVR 1 755 264 015,58
20 Aug 2025
HP13-2022ARV/01: Supply and Delivery of Anti-Retroviral Medicines to the Department of Health for the period ending 30 June 2025.
Health
Ref: HP13-2022ARV/01R 757 076 205,25
24 Jun 2024
AI Analysis
Powered by GeminiAI Forensic Analysis
Get AI-generated audit narratives with key findings and recommended actions.
Paid access from R499/mo
or upgrade to Pro Subscription
Procurement context
Competitive concentration, procurement-intelligence context, province health, and restricted-supplier status are available to forensic subscribers.
Unlock forensic context →CIPC screening signalsClear
No contributing warning signals in the current evidence.
Unlock Full Analysis
Get access to all forensic flags, evidence details, and AI-generated audit narratives.
View Full Intelligence Report
Get complete award history, director network, and compliance analysis.
View Report →